Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Biomarker for CYP3A-mediated Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients

NCT01699360 is registered in ClinicalTrials.gov with Central South University as lead sponsor.

NCT NCT01699360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01699360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Biomarker for CYP3A-mediated Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients
Lead sponsor
Central South University
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2012
Completion date
December 31, 2013
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation